153 related articles for article (PubMed ID: 30337050)
21. A novel method to incorporate the spatial location of the lung dose distribution into predictive radiation pneumonitis modeling.
Vinogradskiy Y; Tucker SL; Liao Z; Martel MK
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1549-55. PubMed ID: 21741183
[TBL] [Abstract][Full Text] [Related]
22. Can stereotactic fractionated radiation therapy become the standard of care for early stage non-small cell lung carcinoma.
Nguyen NP; Garland L; Welsh J; Hamilton R; Cohen D; Vinh-Hung V
Cancer Treat Rev; 2008 Dec; 34(8):719-27. PubMed ID: 18657910
[TBL] [Abstract][Full Text] [Related]
23. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
[TBL] [Abstract][Full Text] [Related]
24. Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).
Chaudhuri AA; Binkley MS; Rigdon J; Carter JN; Aggarwal S; Dudley SA; Qian Y; Kumar KA; Hara WY; Gensheimer M; Nair VS; Maxim PG; Shultz DB; Bush K; Trakul N; Le QT; Diehn M; Loo BW; Guo HH
Radiother Oncol; 2016 Jun; 119(3):454-60. PubMed ID: 27267049
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic body radiation therapy can be used safely to boost residual disease in locally advanced non-small cell lung cancer: a prospective study.
Feddock J; Arnold SM; Shelton BJ; Sinha P; Conrad G; Chen L; Rinehart J; McGarry RC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1325-31. PubMed ID: 23265574
[TBL] [Abstract][Full Text] [Related]
26. Illustration of a fatal radiation-induced lung aneurysm: Is central lung stereotactic radiotherapy to be banned?
Ledoux B; Dupont M; Duplaquet F; Pirard L; Ocak S; Wanet M; Remouchamps V
Cancer Radiother; 2019 Dec; 23(8):926-929. PubMed ID: 31611052
[TBL] [Abstract][Full Text] [Related]
27. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
[TBL] [Abstract][Full Text] [Related]
28. Dose and volume as predictive factors of pulmonary toxicity.
Trodella L; Ramella S; Salvi G; Arcangeli S; Ciresa M; Massaccesi M; Macchia G; D'Angelillo RM
Rays; 2005; 30(2):175-80. PubMed ID: 16294911
[TBL] [Abstract][Full Text] [Related]
29. The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation.
Ren C; Ji T; Liu T; Dang J; Li G
Radiat Oncol; 2018 Apr; 13(1):69. PubMed ID: 29661254
[TBL] [Abstract][Full Text] [Related]
30. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
Kong FM; Hayman JA; Griffith KA; Kalemkerian GP; Arenberg D; Lyons S; Turrisi A; Lichter A; Fraass B; Eisbruch A; Lawrence TS; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1075-86. PubMed ID: 16647222
[TBL] [Abstract][Full Text] [Related]
31. [Intensity-modulated radiation therapy in non-small cell lung cancers].
Ayadi M; Zahra N; Thariat J; Bouilhol G; Boissard P; Van Houtte P; Claude L; Mornex F
Cancer Radiother; 2014 Oct; 18(5-6):406-13. PubMed ID: 25219608
[TBL] [Abstract][Full Text] [Related]
32. [Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer].
Chen L; Zhao Y; Xu F
Zhongguo Fei Ai Za Zhi; 2014 Apr; 17(4):351-6. PubMed ID: 24758912
[TBL] [Abstract][Full Text] [Related]
33. Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy.
Guckenberger M; Baier K; Polat B; Richter A; Krieger T; Wilbert J; Mueller G; Flentje M
Radiother Oncol; 2010 Oct; 97(1):65-70. PubMed ID: 20605245
[TBL] [Abstract][Full Text] [Related]
34. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
35. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy.
Jin H; Tucker SL; Liu HH; Wei X; Yom SS; Wang S; Komaki R; Chen Y; Martel MK; Mohan R; Cox JD; Liao Z
Radiother Oncol; 2009 Jun; 91(3):427-32. PubMed ID: 18937989
[TBL] [Abstract][Full Text] [Related]
36. [Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].
Blais E; Pichon B; Mampuya A; Antoine M; Lagarde P; Kantor G; Breton-Callu C; Lefebvre C; Gerard M; Aamarcha A; Ozsahin M; Bourhis J; Maingon P; Troussier I; Pourel N
Cancer Radiother; 2017 Oct; 21(6-7):584-596. PubMed ID: 28886981
[TBL] [Abstract][Full Text] [Related]
37. Using machine learning to predict radiation pneumonitis in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
Valdes G; Solberg TD; Heskel M; Ungar L; Simone CB
Phys Med Biol; 2016 Aug; 61(16):6105-20. PubMed ID: 27461154
[TBL] [Abstract][Full Text] [Related]
38. Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
Mac Manus MP; Ding Z; Hogg A; Herschtal A; Binns D; Ball DL; Hicks RJ
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1365-71. PubMed ID: 20675076
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic body radiotherapy for stage I non-small-cell lung cancer using higher doses for larger tumors: results of the second study.
Miyakawa A; Shibamoto Y; Baba F; Manabe Y; Murai T; Sugie C; Yanagi T; Takaoka T
Radiat Oncol; 2017 Sep; 12(1):152. PubMed ID: 28893300
[TBL] [Abstract][Full Text] [Related]
40. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma: in regard to Allen et al. (Int J Radiat Oncol Biol Phys 2006;65:640-645).
Komaki R; Liao Z; Liu H; Tucker S; Rice D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1595-6; author reply 1596. PubMed ID: 17126220
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
